These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 37880678)
21. Fibroblast-derived extracellular vesicles contain SFRP1 and mediate pulmonary fibrosis. Burgy O; Mayr CH; Schenesse D; Fousekis Papakonstantinou E; Ballester B; Sengupta A; She Y; Hu Q; Melo-Narvaéz MC; Jain E; Pestoni JC; Mozurak M; Estrada-Bernal A; Onwuka U; Coughlan C; Parimon T; Chen P; Heimerl T; Bange G; Schmeck BT; Lindner M; Hilgendorff A; Ruppert C; Güenther A; Mann M; Yildirim AÖ; Eickelberg O; Jung AL; Schiller HB; Lehmann M; Burgstaller G; Königshoff M JCI Insight; 2024 Aug; 9(18):. PubMed ID: 39315549 [TBL] [Abstract][Full Text] [Related]
22. IL-17A contributes to HSV1 infection-induced acute lung injury in a mouse model of pulmonary fibrosis. Chen T; Qiu H; Zhao MM; Chen SS; Wu Q; Zhou NY; Lu LQ; Song JC; Tang DL; Weng D; Li HP J Cell Mol Med; 2019 Feb; 23(2):908-919. PubMed ID: 30378252 [TBL] [Abstract][Full Text] [Related]
23. [Murine pulmonary fibrosis model induced by repeated low-dose intravenous injection and intratracheal instillation of bleomycin]. Meng J; Peng Z; Tao L Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 38(12):1228-32. PubMed ID: 24384960 [TBL] [Abstract][Full Text] [Related]
24. The fibroblast activation protein alpha as a biomarker of pulmonary fibrosis. Lavis P; Garabet A; Cardozo AK; Bondue B Front Med (Lausanne); 2024; 11():1393778. PubMed ID: 39364020 [TBL] [Abstract][Full Text] [Related]
25. Inhibitory effects of somatostatin analogue in bleomycin-induced pulmonary fibrosis. Hosono T; Bando M; Mizushina Y; Sata M; Hagiwara K; Sugiyama Y Exp Lung Res; 2021; 47(6):280-288. PubMed ID: 33899633 [TBL] [Abstract][Full Text] [Related]
26. Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis. Wei YR; Qiu H; Wu Q; Du YK; Yin ZF; Chen SS; Jin YP; Zhao MM; Wang C; Weng D; Li HP Exp Lung Res; 2016; 42(2):75-86. PubMed ID: 27070485 [TBL] [Abstract][Full Text] [Related]
27. Utilizing MRI, [ Boswinkel M; Raavé R; Veltien A; Scheenen TW; Fransén Petterson N; In 't Zandt R; Olsson LE; von Wachenfeldt K; Heskamp S; Mahmutovic Persson I Front Nucl Med; 2023; 3():1306251. PubMed ID: 39355041 [TBL] [Abstract][Full Text] [Related]
29. Increased expression of OPN contributes to idiopathic pulmonary fibrosis and indicates a poor prognosis. Ji J; Zheng S; Liu Y; Xie T; Zhu X; Nie Y; Shen Y; Han X J Transl Med; 2023 Sep; 21(1):640. PubMed ID: 37726818 [TBL] [Abstract][Full Text] [Related]
30. Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavage. Garcia O; Carraro G; Turcatel G; Hall M; Sedrakyan S; Roche T; Buckley S; Driscoll B; Perin L; Warburton D PLoS One; 2013; 8(8):e71679. PubMed ID: 23967234 [TBL] [Abstract][Full Text] [Related]
32. Reproducible lung protective effects of a TGFβR1/ALK5 inhibitor in a bleomycin-induced and spirometry-confirmed model of IPF in male mice. Petersen AG; Korntner SH; Bousamaki J; Oró D; Arraut AM; Pors SE; Salinas CG; Andersen MW; Madsen MR; Nie Y; Butts J; Roqueta-Rivera M; Simonsen U; Hansen HH; Feigh M Physiol Rep; 2024 Oct; 12(19):e70077. PubMed ID: 39394052 [TBL] [Abstract][Full Text] [Related]
33. Bleomycin-Induced Pulmonary Fibrosis in Transgenic Mice Carrying the Human Tharavecharak S; Fujimoto H; Yasuma T; D'Alessandro-Gabazza CN; Toda M; Tomaru A; Saiki H; Uemura M; Kogue Y; Ito T; Furuhashi K; Okano T; Takeshita A; Nishihama K; Ono R; Hataji O; Nosaka T; Kobayashi T; Gabazza EC Cells; 2024 Sep; 13(18):. PubMed ID: 39329706 [TBL] [Abstract][Full Text] [Related]
34. Deciphering the molecular mechanisms of Maxing Huoqiao Decoction in treating pulmonary fibrosis via transcriptional profiling and circRNA-miRNA-mRNA network analysis. Zhao C; Bu E; Zhang C; Lai R; He J; Guo B; Guo W; Liu L; Pan H Phytomedicine; 2023 Jul; 115():154754. PubMed ID: 37087790 [TBL] [Abstract][Full Text] [Related]
35. Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous Tumor. Hamacher R; Pabst KM; Cheung PF; Heilig CE; Hüllein J; Liffers ST; Borchert S; Costa PF; Schaarschmidt BM; Kessler L; Miera MA; Droste M; Akbulut M; Falkenhorst J; Zarrad F; Kostbade K; Mavroeidi IA; Glimm H; Umutlu L; Schuler M; Hübschmann D; Bauer S; Fröhling S; Herrmann K; Siveke JT; Schildhaus HU; Fendler WP J Nucl Med; 2024 Feb; 65(2):252-257. PubMed ID: 38176718 [TBL] [Abstract][Full Text] [Related]
36. Preventive effect of irbesartan on bleomycin-induced lung injury in mice. Tanaka J; Tajima S; Asakawa K; Sakagami T; Moriyama H; Takada T; Suzuki E; Narita I Respir Investig; 2013 Jun; 51(2):76-83. PubMed ID: 23790735 [TBL] [Abstract][Full Text] [Related]
37. An increase in hyaluronan by lung fibroblasts: a biomarker for intensity and activity of interstitial pulmonary fibrosis? Zhao HW; Lü CJ; Yu RJ; Hou XM Respirology; 1999 Jun; 4(2):131-8. PubMed ID: 10382231 [TBL] [Abstract][Full Text] [Related]
38. Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis. Degryse AL; Tanjore H; Xu XC; Polosukhin VV; Jones BR; McMahon FB; Gleaves LA; Blackwell TS; Lawson WE Am J Physiol Lung Cell Mol Physiol; 2010 Oct; 299(4):L442-52. PubMed ID: 20562227 [TBL] [Abstract][Full Text] [Related]
39. Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis. Acharya PS; Zukas A; Chandan V; Katzenstein AL; Puré E Hum Pathol; 2006 Mar; 37(3):352-60. PubMed ID: 16613331 [TBL] [Abstract][Full Text] [Related]
40. Curcumin inhibition of bleomycin-induced changes in lung collagen synthesis, deposition and assembly. Durairaj P; Venkatesan S; Narayanan V; Babu M Mol Biol Rep; 2021 Dec; 48(12):7775-7785. PubMed ID: 34643929 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]